Skip to main content
SpringerLink
Log in

Approach to the Patient with Nausea and Vomiting in Pregnancy

  • Chapter
  • First Online:
Emergency Department Management of Obstetric Complications

Abstract

A stepwise approach can be utilized for the assessment and treatment of nausea and vomiting in pregnancy and its most severe form, hyperemesis gravidarum. Prompt treatment is important to prevent further progression of symptoms. Diagnostic testing should focus on evaluation for signs of dehydration and electrolyte disturbance. In addition to volume and vitamin repletion, the use of antiemetic medications pyridoxine with doxylamine as first-line therapy is recommended for mild symptoms. Management of persistent/severe symptoms may include use of diphenhydramine, metoclopramide, ondansetron, and promethazine as second-line agents. Hospital admission is reserved for cases of refractory vomiting requiring continued intravenous antiemetics, failed outpatient management of symptoms, and severe fluid or electrolyte imbalance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Einarson TR, Piwko C, Koren G. Prevalence of nausea and vomiting of pregnancy in the USA: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e163–70.

    PubMed  Google Scholar 

  2. Piwko C, Koren G, Babashov V, Vicente C, Einarson TR. Economic Burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol. 2013;20(2):e149–60. Epub 2013 Jul 10

    PubMed  Google Scholar 

  3. Sheehan P. Hyperemesis gravidarum – assessment and management. Aust Fam Physician. 2007;36(9):698–701.

    PubMed  Google Scholar 

  4. Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev. 2016;(5). Art. No.: CD010607.

    Google Scholar 

  5. Eliakim R, Abulafiaz O, Shere DM. Hyperemesis gravidarum: a current review. Am J Perinatol. 2000;17(4):207–18.

    Google Scholar 

  6. Body C, Christie J. Gastrointestinal disease in pregnancy. Gastroenterol Clin North Am. 2016;45:267–83.

    Article  PubMed  Google Scholar 

  7. World Health Organization. International classification of diseases: 10. Version: 2010. 2012. http://tinyurl.com/ctcuekp. Accessed 29 June 2016.

  8. Summers A. Emergency management of hyperemesis gravidarum. Emerg Nurse. 2012;20(4):24–8.

    Article  PubMed  Google Scholar 

  9. Kuscu NK, Koyuncu F. Hyperemesis gravidarum: current concepts and management. Postgrad Med J. 2002;78(916):76–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhang Y, Cantor RM, MacGibbon K, Romero R, Goodwin TM, Mullin PM, Feizo MS. Familial aggregation of hyperemesis gravidarum. Am J Obstet Gynecol. 2011;204(3):230.e1–7.

    Article  Google Scholar 

  11. Schiff MA, Reed SD, Daling JR. The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum. BJOG. 2004;111:27–30.

    Article  PubMed  Google Scholar 

  12. Tan JYL, Loh KC, Yeo GSH, Chee YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG. 2002;109:683–8.

    Article  PubMed  Google Scholar 

  13. Ismail SK, Kenny L. Review on hyperemesis gravidarum. Clin Gastroenterol. 2007;21(5):755–69.

    Google Scholar 

  14. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomised, double masked, placebo controlled trial. Obstet Gynecol. 2001;97:577–82.

    CAS  PubMed  Google Scholar 

  15. Fischer-Rasmussen W, Kiaer SK, Dahl C, Asping U. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991;38(1):19–24.

    Article  CAS  PubMed  Google Scholar 

  16. Borrelli F, Capasso R, Aviello G, et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. 2005;105(4):849–56.

    Article  PubMed  Google Scholar 

  17. American College of Obstetricians and Gynecologists Practice Bulletin. Number 153. 2015. http://dx.doi.org/10.1097/AOG.0000000000001048. Accessed 29 June 2016.

  18. Grooten IJ, et al. A systematic review and meta-analysis of the utility of corticosteroids in the treatment of hyperemesis gravidarum. Nutr Metab Insights. 2015;8(S1):23–32.

    PubMed  Google Scholar 

  19. Duchesnay Inc. Bendectin history. 2013. http://www.bendectin.com/en. Accessed 29 June 2016

  20. American College of Obstetrics and Gynecology. Practice Bulletin No 153.

    Google Scholar 

  21. Kutcher JS, Engle A, Firth J, Lamm SH. Bendectin and birth defects. II: ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003;67(2):88–97.

    Article  CAS  PubMed  Google Scholar 

  22. McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology. 1994;50(1):27–37.

    Article  CAS  PubMed  Google Scholar 

  23. Goodwin T. Murphy hyperemesis gravidarum. Obstet Gynecol Clin. 2008;35(3):401–17.

    Article  Google Scholar 

  24. Pope E, Maltepe C, Koren G. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: a matched, controlled cohort study. J Clin Pharmacol. 2015;55(7):809–14.

    Article  CAS  PubMed  Google Scholar 

  25. Madjunkova S, Maltepe C, Koren G. The delayed-release combination of doxylamine and pyridoxine (Diclegis/Diclectin) for the treatment of nausea and vomiting of pregnancy. Paediatr Drugs. 2014;16(3):199–211.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tobin S. Management of nausea and vomiting of pregnancy after discharge from the Emergency Department. Emerg Med News Duchesnay Suppl. 2016.

    Google Scholar 

  27. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528–35.

    Article  CAS  PubMed  Google Scholar 

  28. Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S256–61. 37

    Article  CAS  PubMed  Google Scholar 

  29. Mayhall EA, Gray R, Lopes V, Matteson KA. Comparison of antiemetics for nausea and vomiting of pregnancy in an emergency department setting. Am J Emerg Med. 2015;33:882–6.

    Article  PubMed  Google Scholar 

  30. Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy. Obstet Gynecol. 2014;124:735–42.

    Article  CAS  PubMed  Google Scholar 

  31. Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014;123:1272–9.

    Article  CAS  PubMed  Google Scholar 

  32. Pasternak B, Svanström H, Hvild A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368:814–23. Erratum in N Engl J Med 2013;368:2146

    Article  CAS  PubMed  Google Scholar 

  33. Danielsson B, Wikner BN, Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol. 2014;50:134–7.

    Article  CAS  PubMed  Google Scholar 

  34. Siminerio L, Bodnar L, Venkataramanan R, Caritis S. Ondansetron use in pregnancy. Obstet Gynecol. 2016;127:873–7.

    Article  CAS  PubMed  Google Scholar 

  35. Carstairs S. Ondansetron use in pregnancy and birth defects. Obstet Gynecol. 2016;127:878–83.

    Article  CAS  PubMed  Google Scholar 

  36. Freedman SB, Uleryk E, Rumantir M, et al. Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis. Ann Emerg Med. 2014;64(1):19–25. e16

    Article  PubMed  Google Scholar 

  37. Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585. e581–7. Discussion 683–684, e581–587.

    Google Scholar 

  38. Skuladottir H, Wilcox AJ, Ma C, et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Painter RC, Roseboom TJ, de Rooij SR. Long-term effects of prenatal stress and glucocorticoid exposure. Birth Defects Res C Embryo Today. 2012;96(4):315–24.

    Article  CAS  PubMed  Google Scholar 

  40. Togay-Isikay C, Yigit A, Mutluer N. Wernicke’s encephalopathy due to hyperemesis gravidarum: an under-recognised condition. Aust N Z J Obstet Gynaecol. 2001;41:453–6.

    Article  CAS  PubMed  Google Scholar 

  41. Chiossi G, Neri I, Cavazzuti M, Basso G, Facchinetti F. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006;61(4):255–68.

    Article  PubMed  Google Scholar 

  42. Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. 2014. https://federalregister.gov/a/2014-28241.

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, MedStar Washington Hospital Center, 110 Irving St NW, Washington, DC, 20010, USA

    Lindsey DeGeorge M.D. & Lauren Wiesner M.D.

Authors
  1. Lindsey DeGeorge M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lauren Wiesner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lauren Wiesner M.D. .

Editor information

Editors and Affiliations

  1. MedStar Georgetown University Hospital and MedStar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC, USA

    Joelle Borhart

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

DeGeorge, L., Wiesner, L. (2017). Approach to the Patient with Nausea and Vomiting in Pregnancy. In: Borhart, J. (eds) Emergency Department Management of Obstetric Complications. Springer, Cham. https://doi.org/10.1007/978-3-319-54410-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54410-6_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54409-0

  • Online ISBN: 978-3-319-54410-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation